drugset / Trial / NCT05577845
5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Safety \& Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) versus Loperamide for the Treatment of Low Anterior Resection Syndrome (RALLARS): Multicenter Randomized Controlled Trial
Timeline
- Start
- 2023-03-27
- Primary completion
- 2025-12
- Completion
- 2032-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramosetron | Small molecule | — | — |
Indications
No indication recorded.